罗恩 |
R026072-10mg |
10mg |
5~7个工作日 |
475108-18-0 |
Tivozanib (AV-951) Tivozanib (AV-951) |
99% |
1,098.00
1,098.00
|
|
罗恩 |
R026072-50mg |
50mg |
5~7个工作日 |
475108-18-0 |
Tivozanib (AV-951) Tivozanib (AV-951) |
99% |
9,460.00
9,460.00
|
|
罗恩 |
R026072-5mg |
5mg |
5~7个工作日 |
475108-18-0 |
Tivozanib (AV-951) Tivozanib (AV-951) |
99% |
575.00
575.00
|
|
阿拉丁 |
T126012-5mg |
5mg |
现货 |
475108-18-0 |
Tivozanib (AV-951),抑制剂 Tivozanib (AV-951) |
Moligand™, ≥98% |
649.90
649.90
|
|
阿拉丁 |
T126012-25mg |
25mg |
现货 |
475108-18-0 |
Tivozanib (AV-951),抑制剂 Tivozanib (AV-951) |
Moligand™, ≥98% |
964.90
964.90
|
|
阿拉丁 |
T126012-100mg |
100mg |
现货 |
475108-18-0 |
Tivozanib (AV-951),抑制剂 Tivozanib (AV-951) |
Moligand™, ≥98% |
1,286.90
1,286.90
|
|
阿拉丁 |
T409225-1ml |
1ml |
现货 |
475108-18-0 |
Tivozanib (AV-951) Tivozanib (AV-951) |
Moligand™, 10mM in DMSO |
532.72
532.72
|
|
麦克林/Macklin |
T855192-25mg |
25mg |
现货 |
475108-18-0 |
Tivozanib (AV-951) Tivozanib (AV-951) |
95% |
1,999.00
1,999.00
|
|
麦克林/Macklin |
T855192-5mg |
5mg |
现货 |
475108-18-0 |
Tivozanib (AV-951) Tivozanib (AV-951) |
95% |
585.00
585.00
|
|
麦克林/Macklin |
T855192-100mg |
100mg |
现货 |
475108-18-0 |
Tivozanib (AV-951) Tivozanib (AV-951) |
95% |
5,220.00
5,220.00
|
|
麦克林/Macklin |
T960281-5mg |
5mg |
现货 |
475108-18-0 |
Tivozanib (AV-951) Tivozanib (AV-951) |
≥99% |
745.00
745.00
|
|
麦克林/Macklin |
T960281-25mg |
25mg |
现货 |
475108-18-0 |
Tivozanib (AV-951) Tivozanib (AV-951) |
≥99% |
2,480.00
2,480.00
|
|
麦克林/Macklin |
T960281-100mg |
100mg |
现货 |
475108-18-0 |
Tivozanib (AV-951) Tivozanib (AV-951) |
≥99% |
6,470.00
6,470.00
|
|
毕得 |
BD208778-50mg |
50mg |
现货 |
475108-18-0 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-Chloro-4-((6,7-dimethox... |
98+% |
886.00
886.00
|
|
毕得 |
BD208778-100mg |
100mg |
现货 |
475108-18-0 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-Chloro-4-((6,7-dimethox... |
98+% |
1,286.00
1,286.00
|
|
毕得 |
BD208778-5mg |
5mg |
现货 |
475108-18-0 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-Chloro-4-((6,7-dimethox... |
98+% |
154.00
154.00
|
|
毕得 |
BD208778-250mg |
250mg |
现货 |
475108-18-0 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-Chloro-4-((6,7-dimethox... |
98+% |
2,407.00
2,407.00
|
|
毕得 |
BD208778-1g |
1g |
现货 |
475108-18-0 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基... 1-(2-Chloro-4-((6,7-dimethox... |
98+% |
6,496.00
6,496.00
|
|
梯希爱 |
T4285-100MG |
100MG |
现货 |
475108-18-0 |
替沃扎尼 Tivozani |
98.0% |
1,790.00
1,790.00
|
|
源叶 |
S27192-5mg |
5mg |
期货,请咨询 |
475108-18-0 |
Tivozanib (AV-951) Tivozanib (AV-951) |
>96%,VEGFR抑制剂 |
400.00
400.00
|
|